FDA Inspection
VitalantVitalant – FDA Inspection, Jan 22, 2014
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on January 22, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Vitalant
- Inspection Date
- January 22, 2014
- Product Type
- Biologics
View Company Profile
ID · e0256db4-e711-4999-8a24-97262ebece09
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 862841
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)(20)Donor deferral
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Vitalant
16| Date | Classification | Office | Project area |
|---|---|---|---|
| September 4, 2025 | Not classified | Philadelphia District Office | |
| December 1, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 23, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 28, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 28, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1281129 - 2025-09-04
- FDA Inspection 1193237 - 2022-12-01
- FDA Inspection 1100311 - 2019-08-23
- FDA Inspection 1106128 - 2019-06-28
- FDA Inspection 1102324 - 2019-06-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.